5-amino-1MQ | Peptide Research Hub

At a Glance

5-amino-1MQ is a research small molecule discussed in the context of NNMT (nicotinamide N-methyltransferase) inhibition. High-quality human evidence and a well-defined safety profile are not established.

⚠️ Research Status: This dossier is an intake stub pending literature curation. It is not medical advice. Protocol/dosing guidance is intentionally not included.

Intake Notes (Unreviewed)

Tags (from internal sheet): Muscles; Weight Loss; Immune system
Reported adverse effects (unverified): difficulty sleeping; difficulty participating in exercise

Mechanism of Action (TBD)

Candidate target: NNMT (needs primary sources).

Evidence Summary

Low Confidence Review

Literature curation pending.

Safety & Unknowns

No consolidated human safety dataset identified in this intake stub.
Quality control and purity vary widely for research-grade materials.

Regulatory Status

Region	Status
United States (FDA)	Not approved
European Union (EMA)	Not approved
WADA	Check current list (status may change)

Changelog

Date	Change
2026-01-23	Added intake stub from compounds sheet